Archimedes™, a novel automated peritoneal dialysis system which is now FDA 510(k)-cleared, enables bloodless dialysis for End Stage Kidney Disease (ESKD) patients in the home or clinic setting.
Hosted on MSN
Montes Archimedes Acquisition (ROIV) Surges 7.8%: Is This an Indication of Further Gains?
Roivant Sciences Ltd. (ROIV) shares ended the last trading session 7.8% higher at $15.28. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback